300406 九強生物
按盤價 
18.530 +0.040 (+0.216%)
18.530 +0.040 (+0.216%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.187 | 14.973 | 12.663 | 13.362 | 4.340 |
| 總資產報酬率 ROA (%) | 2.308 | 10.701 | 8.712 | 9.794 | 3.671 |
| 投入資產回報率 ROIC (%) | 2.425 | 11.269 | 9.230 | 10.732 | 3.129 | 邊際利潤分析 |
| 銷售毛利率 (%) | 76.861 | 74.664 | 74.590 | 72.065 | 61.492 |
| 營業利潤率 (%) | 36.655 | 34.099 | 30.147 | 33.505 | 18.045 |
| 息稅前利潤/營業總收入 (%) | 38.860 | 36.504 | 32.932 | 34.711 | 16.541 |
| 淨利潤/營業總收入 (%) | 30.521 | 29.976 | 26.108 | 29.365 | 14.347 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 99.529 | 99.276 | 104.893 | 102.446 | 135.002 |
| 價值變動淨收益/利潤總額(%) | 0.783 | 3.498 | 4.245 | 2.148 | 0.881 |
| 營業外收支淨額/利潤總額(%) | -1.385 | -0.054 | -1.365 | 0.208 | -11.772 | 償債能力分析 |
| 流動比率 (X) | 11.081 | 7.856 | 6.936 | 2.865 | 7.305 |
| 速動比率 (X) | 10.124 | 7.083 | 6.199 | 2.451 | 6.285 |
| 資產負債率 (%) | 27.203 | 28.096 | 29.138 | 32.557 | 13.629 |
| 帶息債務/全部投入資本 (%) | 23.360 | 23.251 | 25.034 | 27.848 | -- |
| 股東權益/帶息債務 (%) | 325.584 | 327.415 | 296.779 | 256.203 | 1,072.743 |
| 股東權益/負債合計 (%) | 267.986 | 256.127 | 243.373 | 204.385 | 591.917 |
| 利息保障倍數 (X) | 14.360 | 15.064 | 10.321 | 30.562 | 41.779 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 254.968 | 218.230 | 229.676 | 187.216 | 0.000 |
| 存貨周轉天數 (天) | 230.371 | 183.318 | 221.139 | 201.219 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/04/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
